108 related articles for article (PubMed ID: 7987211)
1. The pharmacophore of the human C5a anaphylatoxin.
Toth MJ; Huwyler L; Boyar WC; Braunwalder AF; Yarwood D; Hadala J; Haston WO; Sills MA; Seligmann B; Galakatos N
Protein Sci; 1994 Aug; 3(8):1159-68. PubMed ID: 7987211
[TBL] [Abstract][Full Text] [Related]
2. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
3. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
[TBL] [Abstract][Full Text] [Related]
4. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
Zhang X; Boyar W; Galakatos N; Gonnella NC
Protein Sci; 1997 Jan; 6(1):65-72. PubMed ID: 9007977
[TBL] [Abstract][Full Text] [Related]
6. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
Nikiforovich GV; Marshall GR; Baranski TJ
Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the C-terminal C5a effector site with short synthetic C5a analog peptides.
Köhl J; Lübbers B; Klos A; Bautsch W; Casaretto M
Eur J Immunol; 1993 Mar; 23(3):646-52. PubMed ID: 8383599
[TBL] [Abstract][Full Text] [Related]
8. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.
Carney DF; Hugli TE
Protein Sci; 1993 Sep; 2(9):1391-9. PubMed ID: 8401225
[TBL] [Abstract][Full Text] [Related]
9. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
[TBL] [Abstract][Full Text] [Related]
10. Weak response of porcine C5a receptor towards human C5a in miniature pig endothelial cells and PMNs.
Yi KS; Lee S; Kang YH; Bae YS; Hwang SY; Ha I; Kim H; Kim MS; Cho B; Kang HJ; Bang KT; Kim JY; Yang J; Chung J; Ahn C
Xenotransplantation; 2007 Nov; 14(6):563-71. PubMed ID: 17991144
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
12. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
[TBL] [Abstract][Full Text] [Related]
13. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.
Cui L; Carney DF; Hugli TE
Protein Sci; 1994 Aug; 3(8):1169-77. PubMed ID: 7987212
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis.
Morgan EL; Sanderson S; Scholz W; Noonan DJ; Weigle WO; Hugli TE
J Immunol; 1992 Jun; 148(12):3937-42. PubMed ID: 1602137
[TBL] [Abstract][Full Text] [Related]
15. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
16. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
17. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.
Pellas TC; Boyar W; van Oostrum J; Wasvary J; Fryer LR; Pastor G; Sills M; Braunwalder A; Yarwood DR; Kramer R; Kimble E; Hadala J; Haston W; Moreira-Ludewig R; Uziel-Fusi S; Peters P; Bill K; Wennogle LP
J Immunol; 1998 Jun; 160(11):5616-21. PubMed ID: 9605167
[TBL] [Abstract][Full Text] [Related]
18. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
[TBL] [Abstract][Full Text] [Related]
19. C5a structural requirements for neutrophil receptor interaction.
Mollison KW; Fey TA; Krause RA; Miller L; Edalji RP; Conway RG; Mandecki W; Shallcross MA; Kawai M; Or YS
Agents Actions Suppl; 1991; 35():17-21. PubMed ID: 1664187
[TBL] [Abstract][Full Text] [Related]
20. Identification of a receptor-binding region in the core segment of the human anaphylatoxin C5a.
Vlattas I; Sytwu II; Dellureficio J; Stanton J; Braunwalder AF; Galakatos N; Kramer R; Seligmann B; Sills MA; Wasvary J
J Med Chem; 1994 Aug; 37(17):2783-90. PubMed ID: 8064805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
